|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2005-1-6
|
|
pubmed:abstractText |
Febrile neutropenia (FN) remains a major dose-limiting complication among patients treated with chemotherapy. Haematopoietic colony stimulating factors (G-CSF and GM-CSF) made possible a significant improvement in the management of FN, both in the therapeutic and in the prophylactic approach. The use of antibiotic prophylaxis also permits a definite reduction of severe infections during neutropenia. Nevertheless, the possible role of these two interventions for secondary prevention of FN is still unclear.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0941-4355
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
725-30
|
|
pubmed:meshHeading |
pubmed-meshheading:15235901-Administration, Oral,
pubmed-meshheading:15235901-Adult,
pubmed-meshheading:15235901-Aged,
pubmed-meshheading:15235901-Amoxicillin-Potassium Clavulanate Combination,
pubmed-meshheading:15235901-Anti-Bacterial Agents,
pubmed-meshheading:15235901-Anti-Infective Agents,
pubmed-meshheading:15235901-Antineoplastic Agents,
pubmed-meshheading:15235901-Ciprofloxacin,
pubmed-meshheading:15235901-Drug Therapy, Combination,
pubmed-meshheading:15235901-Female,
pubmed-meshheading:15235901-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:15235901-Humans,
pubmed-meshheading:15235901-Injections, Subcutaneous,
pubmed-meshheading:15235901-Male,
pubmed-meshheading:15235901-Middle Aged,
pubmed-meshheading:15235901-Neutropenia,
pubmed-meshheading:15235901-Prospective Studies
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
A prospective randomised evaluation of G-CSF or G-CSF plus oral antibiotics in chemotherapy-treated patients at high risk of developing febrile neutropenia.
|
|
pubmed:affiliation |
Department of Médecine Interne and Laboratoire d'Investigations Cliniques, H-J Tagnon, Institut Jules Bordet, Centre des Tumeurs de l'Université Libre de Bruxelles, Rue Héger Bordet 1, 1000 Brussels, Belgium. yassine.lalami@bordet.be
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study
|
